12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Aclarion (NASDAQ:ACON) shares increased by 148.3% to $1.47 during Tuesday’s pre-market session. The company’s market cap stands…
HeartBeam Enters Into Strategic Alliance Agreement with Samsung; Will Identify And Define Opportunities For Collaboration, Tapping The HeartBeam Team’s Expertise And Patented Technology In The Assessment And Monitoring Of Cardiac Symptoms
HeartBeam, Inc. (NASDAQ:BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, today announced that it has entered
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers HeartBeam (NASDAQ:BEAT) stock rose 20.1% to $2.42 during Thursday’s pre-market session. The company’s market cap stands at…
HeartBeam Announces Automated Cardiac Detection Patent Granted For HeartBeam AIMIGo System
Patent Underscores AI for Vectorcardiography (VECG) IP Leadership Effort
HeartBeam, Inc. (NASDAQ:BEAT), a cardiac technology company that has developed the first and only 3D vector electrocardiogram (VECG) platform
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Innovative Eyewear (NASDAQ:LUCY) shares moved upwards by 146.6% to $3.6 during Tuesday’s regular session. Innovative Eyewear’s stock…
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear.
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Innovative Eyewear (NASDAQ:LUCY) stock moved upwards by 128.1% to $3.33 during Tuesday’s pre-market session. The market value…
HeartBeam Appoints Robert Eno As President
Senior Medical Technology Executive to Enhance Company's Strategic and Operations Capabilities
HeartBeam, Inc. (NASDAQ:BEAT), a cardiac technology company that has developed the first and only 3D-vector
HeartBeam Partners With Evolve Manufacturing To Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device
Partnership Positions AIMIGo for Early Market Testing in Q2 2023 After Expected FDA Clearance
HeartBeam, Inc. (NASDAQ:BEAT), a cardiac technology company that has developed the first and only 3D-vector